Analysts/Institutional Investor Meet/Con. Call Updates

Date: 13 August 2026 The Secretary The Secretary BSE Limited The National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers Exchange Plaza, Plot No. C/1. G Block Dalal Street Bandra -Kurla Complex, Bandra (East) Mumbai - 400 001 Mumbai- 400 051 Scrip Code: 544293 Scrip Symbol : SURAKSHA Dear Sir / Ma’am, Reg: Disclosure under Regulation 30(6) and 46(2) of the SEBI (Listing Obligations and Disclosures Requirements) Regulations, 2015 Sub: Intimation of the audio recording of Analysts / Institutional Investors / Organisations meet- ‘Earnings Call’ Pursuant to Regulation 30(6) and 46(2) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that the audio recording of the Earnings Call held today, i.e. Thursday, 13 August 2026 at 11:30 a.m. (IST) in relation to the unaudited (standalone and consolidated) Financial Results of the Company for the quarter ended 30 June 2026 and other business discussions, is available on the Company’s website at: https://www.surakshanet.com/audio/Suraksha%20-%20Q4%20&%20FY26-27%20-%20Concall- audio-recording.mp3 You are requested to kindly take the same on record. For Suraksha Diagnostic Limited Ritu Mittal Joint Managing Director & CEO DIN: 00165886 Encl.: as above Suraksha Diagnostic Limited (Formerly known as Suraksha Diagnostic Private Limited) CIN: L85110WB2005PLC102265 Reg Office: 12/1, Premises No. 02-0327, DG Block, Action Area 1D, New Town, Kolkata-700 156, West Bengal, India E-mail: investors@surakshanet.com I Website: www.surakshanet.com Phone:(033) 6605 9750